# Eurofins Amatsi Analytics – FDA Inspection, Nov 3, 2023

Source: https://www.keypedia.com/records/fda_inspections/eurofins-amatsi-analytics/aed3d852-5c11-41b6-a617-8bef1b4eb2c9
Source feed: FDA_Inspections

> FDA inspection 1224183 of Eurofins Amatsi Analytics, November 03, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1224183
- Company Name: Eurofins Amatsi Analytics
- Inspection Date: 2023-11-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1174252 - 2021-08-05
- FDA Inspection 990192 - 2016-09-28
- FDA Inspection 865532 - 2014-02-04
- [FDA Inspection 706532 - 2010-10-08](https://www.keypedia.com/records/fda_inspections/eurofins-amatsi-analytics/ca462167-b1c1-4c90-aa35-ff2f694a06f4)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/yiying-e-chen/1fcf176f-3d89-45e3-8859-64f614cf14b3)

Company: https://www.keypedia.com/companies/eurofins-amatsi-analytics/b634a442-c268-4779-920a-c50afd3e3af2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c